Flupentixol + Melitracen Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: Flupentixol 0.5 mg + Melitracen 10 mg
Reference Brands: Deanxit(EU)
Category: Antipsychotropic Drugs
Flupentixol + melitracen tablets (0.5 mg + 10 mg) combine a low-dose antipsychotic with a tricyclic antidepressant for mild to moderate depression with anxiety. The combination is marketed as Deanxit and generics in Asia, the Middle East and parts of Europe, but not in the US or UK. PharmaTradz sources it for importers, hospitals and tenders, and shares GMP certificates and CoA before you commit.
Manufacture or export Flupentixol + Melitracen? List it or send an offer →
Product Description: Flupentixol + Melitracen is a well-established combination therapy for managing depression and anxiety, especially in psychosomatic and somatic conditions. Available as oral tablets (Flupentixol 0.5 mg + Melitracen 10 mg), this dual-action formulation provides both antidepressant and anxiolytic benefits. The most popular brand, Deanxit, is marketed in various EU and international markets. Although not FDA-approved for use in the US, this fixed-dose combination sees significant demand in Europe, Asia, and the Middle East. Global pharmaceutical importers and B2B buyers rely on GMP-compliant suppliers to source Flupentixol + Melitracen for mental health therapeutic segments.
Flupentixol + Melitracen — third party manufacturing & bulk supply
Flupentixol + Melitracen is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Flupentixol + Melitracen is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Flupentixol + Melitracen listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Flupentixol + Melitracen →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Usually one or two tablets in the morning, with a second dose at midday if needed; it is avoided late in the day because it can cause insomnia.
People recovering from a heart attack, with heart block, or taking MAO inhibitors, because of the tricyclic component.
In many Asian, Middle Eastern, African and some European countries; it is not approved in the US or UK.
Related Products
Sodium Valproate + Valproic Acid Tablet
Strength:
200 mg, 300 mg, 500 mg
Form: Tablets
Reference Brands: Depakote(US), Epilim Chrono(EU)
View DetailsAripiprazole Injection
Strength:
Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly)
Form: Intramuscular (IM) Injection
Reference Brands: Abilify(EU & US)
View DetailsSodium Valproate + Valproic Acid Solution
Strength:
200 mg/5 mL, 250 mg/5 mL
Form: Oral Solution/Syrup
Reference Brands: Depakote(US), Epilim Chrono(EU)
View DetailsAripiprazole Solution
Strength:
1 mg/mL
Form: Oral Solution
Reference Brands: Abilify(EU & US)
View DetailsDiazepam Oral Tablets
Strength:
2 mg, 5 mg, 10 mg
Form: Oral Tablets
Reference Brands: Valium®(EU & US)
View DetailsDiazepam Oral Solution
Strength:
2.5 mg/mL, 5 mg/mL
Form: Oral Solution
Reference Brands: Valium®(EU & US)
View DetailsDiazepam Intramuscular (IM) / Intravenous (IV) Injection
Strength:
5 mg/mL
Form: Intramuscular (IM) / Intravenous (IV) Injection
Reference Brands: Valium®(EU & US)
View DetailsAlprazolam 2 mg Oral Tablets (Immediate-Release)
Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg
Form: Oral tablets (immediate-release)
Reference Brands: Xanax®(US & EU), Niravam®, Alprazolam Intensol®
View DetailsUsually answered within 48 hours | GMP documents shared before you commit